• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心肌病中基因和通路的生物信息学分析与鉴定

Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy.

作者信息

Cao Jing, Liu Zhaoya, Liu Jie, Li Chan, Zhang Guogang, Shi Ruizheng

机构信息

Department of Cardiovascular Medicine, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.

Department of Geriatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.

出版信息

Int J Gen Med. 2021 Sep 21;14:5927-5937. doi: 10.2147/IJGM.S329980. eCollection 2021.

DOI:10.2147/IJGM.S329980
PMID:34584445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8464396/
Abstract

PURPOSE

Ischemic cardiomyopathy (ICM) is considered to be the most common cause of heart failure, with high prevalence and mortality. This study aimed to investigate the different expressed genes (DEGs) and pathways in the pathogenesis of ICM using bioinformatics analysis.

METHODS

The control and ICM datasets GSE116250, GSE46224 and GSE5406 were collected from the gene expression omnibus (GEO) database. DEGs were identified using limma package of R software, and co-expressed genes were identified using Venn diagrams. Then, the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to explore the biological functions and signaling pathways. Protein-protein interaction (PPI) networks were assembled with Cytoscape software to identify hub genes related to the pathogenesis of ICM. RT-PCR of Heart tissues (n=2 for non-failing controls and n=4 for ischemic cardiomyopathy patients) was used to validate the bioinformatic results.

RESULTS

A total of 844 DEGs were screened from GSE116250, of which 447 were up-regulated genes and 397 were down-regulated genes, respectively. A total of 99 DEGs were singled out from GSE46224, of which 58 were up-regulated genes and 41 were down-regulated genes, respectively. Thirty DEGs were screened from GSE5406, including 10 genes with up-regulated expression and 20 genes with down-regulated expression. Five up-regulated and 3 down-regulated co-expressed DEGs were intersected in three datasets. GO and KEGG pathway analyses revealed that DEGs are mainly enriched in collagen fibril organization, protein digestion and absorption, AGE-RAGE signaling pathway and other related pathways. Collagen alpha-1(III) chain (COL3A1), collagen alpha-2(I) chain (COL1A2) and lumican (LUM) are the three hub genes in all three datasets through PPI network analysis. The expression of 5 DEGs (SERPINA3, FCN3, COL3A1, HBB, MXRA5) in heart tissues by qRT-PCR results was consistent with our GEO analysis, while expression of 3 DEGs (ASPN, LUM, COL1A2) was opposite with GEO analysis.

CONCLUSION

These findings from this bioinformatics network analysis investigated key hub genes, which contributed to better understanding the mechanism and new therapeutic targets of ICM.

摘要

目的

缺血性心肌病(ICM)被认为是心力衰竭最常见的病因,具有高患病率和死亡率。本研究旨在通过生物信息学分析探讨ICM发病机制中的差异表达基因(DEGs)和信号通路。

方法

从基因表达综合数据库(GEO)收集对照和ICM数据集GSE116250、GSE46224和GSE5406。使用R软件的limma包鉴定DEGs,并使用维恩图鉴定共表达基因。然后,进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析,以探索生物学功能和信号通路。使用Cytoscape软件构建蛋白质-蛋白质相互作用(PPI)网络,以鉴定与ICM发病机制相关的枢纽基因。对心脏组织(非衰竭对照组n = 2,缺血性心肌病患者n = 4)进行RT-PCR以验证生物信息学结果。

结果

从GSE116250中筛选出总共844个DEGs,其中分别有447个上调基因和397个下调基因。从GSE46224中选出总共99个DEGs,其中分别有58个上调基因和41个下调基因。从GSE5406中筛选出30个DEGs,包括10个表达上调的基因和20个表达下调的基因。在三个数据集中交集出5个上调和3个下调的共表达DEGs。GO和KEGG通路分析显示,DEGs主要富集在胶原纤维组织、蛋白质消化和吸收、AGE-RAGE信号通路及其他相关通路。通过PPI网络分析,胶原α-1(III)链(COL3A1)、胶原α-2(I)链(COL1A2)和纤连蛋白(LUM)是所有三个数据集中的三个枢纽基因。qRT-PCR结果显示心脏组织中5个DEGs(SERPINA3, FCN3, COL3A1, HBB, MXRA5)的表达与我们的GEO分析一致,而3个DEGs(ASPN, LUM, COL1A2)的表达与GEO分析相反。

结论

该生物信息学网络分析的这些发现研究了关键枢纽基因,有助于更好地理解ICM的机制和新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/601438871273/IJGM-14-5927-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/5b67d513843d/IJGM-14-5927-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/d630ae1725ee/IJGM-14-5927-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/41af638b8254/IJGM-14-5927-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/a3e8f77bb23c/IJGM-14-5927-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/f98f269bb80f/IJGM-14-5927-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/601438871273/IJGM-14-5927-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/5b67d513843d/IJGM-14-5927-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/d630ae1725ee/IJGM-14-5927-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/41af638b8254/IJGM-14-5927-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/a3e8f77bb23c/IJGM-14-5927-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/f98f269bb80f/IJGM-14-5927-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a7/8464396/601438871273/IJGM-14-5927-g0006.jpg

相似文献

1
Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy.缺血性心肌病中基因和通路的生物信息学分析与鉴定
Int J Gen Med. 2021 Sep 21;14:5927-5937. doi: 10.2147/IJGM.S329980. eCollection 2021.
2
Analysis of susceptibility genes and myocardial infarction risk correlation of ischemic cardiomyopathy based on bioinformatics.基于生物信息学的缺血性心肌病易感性基因及心肌梗死风险相关性分析
J Thorac Dis. 2022 Sep;14(9):3445-3453. doi: 10.21037/jtd-22-1060.
3
Identification of abnormally methylated-differentially expressed genes and pathways in osteoarthritis: a comprehensive bioinformatic study.骨关节炎中异常甲基化差异表达基因和通路的鉴定:一项全面的生物信息学研究。
Clin Rheumatol. 2021 Aug;40(8):3247-3256. doi: 10.1007/s10067-020-05539-w. Epub 2021 Jan 9.
4
Identifying critical genes and pathways of doxorubicin-induced cardiomyopathy via bioinformatics analysis.通过生物信息学分析鉴定多柔比星诱导性心肌病的关键基因和通路。
Eur Rev Med Pharmacol Sci. 2024 Mar;28(5):1641-1650. doi: 10.26355/eurrev_202403_35578.
5
Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.扩张型心肌病潜在机制和生物标志物的生物信息学预测
World J Cardiol. 2022 May 26;14(5):282-296. doi: 10.4330/wjc.v14.i5.282.
6
Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.基于小鼠转录组测序的糖尿病肾病关键生物标志物的生物信息学预测和实验验证。
PeerJ. 2022 Sep 20;10:e13932. doi: 10.7717/peerj.13932. eCollection 2022.
7
Investigation of the Underlying Genes and Mechanism of Macrophage-Enriched Ruptured Atherosclerotic Plaques Using Bioinformatics Method.采用生物信息学方法研究富含巨噬细胞的破裂粥样硬化斑块的潜在基因和机制。
J Atheroscler Thromb. 2019 Jul 1;26(7):636-658. doi: 10.5551/jat.45963. Epub 2019 Jan 15.
8
Identification of differentially expressed genes to predict the risk of heart failure in older patients with hypertrophic cardiomyopathy.鉴定差异表达基因以预测老年肥厚型心肌病患者心力衰竭的风险。
Aging (Albany NY). 2024 Jun 20;16(13):10860-10867. doi: 10.18632/aging.205956.
9
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.
10
Identification of potential crucial genes associated with early-onset preeclampsia via bioinformatic analysis.通过生物信息学分析鉴定与早发性子痫前期相关的潜在关键基因。
Pregnancy Hypertens. 2021 Jun;24:27-36. doi: 10.1016/j.preghy.2021.02.007. Epub 2021 Feb 23.

引用本文的文献

1
Identification of key genes as diagnostic biomarkers for IBD using bioinformatics and machine learning.利用生物信息学和机器学习鉴定关键基因作为炎症性肠病的诊断生物标志物
J Transl Med. 2025 Jul 3;23(1):738. doi: 10.1186/s12967-025-06531-1.
2
Identification of novel ferroptosis-related biomarkers associated with the oxidative stress pathways in ischemic cardiomyopathy.缺血性心肌病中与氧化应激途径相关的新型铁死亡相关生物标志物的鉴定。
Int J Cardiol Heart Vasc. 2024 Dec 21;56:101584. doi: 10.1016/j.ijcha.2024.101584. eCollection 2025 Feb.
3
Identifying as a Biomarker Covering Multiple Pathogenic Pathways for Diagnosing Heart Failure: From Machine Learning to Mechanism Interpretation.

本文引用的文献

1
Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth.皮肤组织的无标记红外光谱组织学 第二部分:源自核心蛋白聚糖的肽对黑色素瘤生长的影响
Front Cell Dev Biol. 2020 May 29;8:377. doi: 10.3389/fcell.2020.00377. eCollection 2020.
2
LUM Expression and Its Prognostic Significance in Gastric Cancer.LUM在胃癌中的表达及其预后意义
Front Oncol. 2020 May 15;10:605. doi: 10.3389/fonc.2020.00605. eCollection 2020.
3
Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate.
鉴定作为一种生物标志物,涵盖多种心力衰竭发病机制的诊断:从机器学习到机制阐释。
Biomolecules. 2024 Feb 2;14(2):179. doi: 10.3390/biom14020179.
4
Identification of Co-diagnostic Genes for Heart Failure and Hepatocellular Carcinoma Through WGCNA and Machine Learning Algorithms.通过 WGCNA 和机器学习算法鉴定心力衰竭和肝细胞癌的共诊断基因。
Mol Biotechnol. 2024 May;66(5):1229-1245. doi: 10.1007/s12033-023-01025-1. Epub 2024 Jan 18.
5
Current Insights and Future Directions in the Treatment of Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭治疗的现状与展望。
Int J Mol Sci. 2023 Dec 28;25(1):440. doi: 10.3390/ijms25010440.
6
Exploring Potential Biomarkers and Molecular Mechanisms of Ischemic Cardiomyopathy and COVID-19 Comorbidity Based on Bioinformatics and Systems Biology.基于生物信息学和系统生物学探索缺血性心肌病与 COVID-19 合并症的潜在生物标志物和分子机制。
Int J Mol Sci. 2023 Mar 30;24(7):6511. doi: 10.3390/ijms24076511.
7
Inhibitory effect of on atherosclerosis through the p53 pathway.通过p53途径对动脉粥样硬化的抑制作用。 (你提供的原文不完整,这里推测补充了“某种物质”之类的表述以让句子完整表意)
Ann Transl Med. 2022 Sep;10(18):1008. doi: 10.21037/atm-22-4372.
8
Analysis of susceptibility genes and myocardial infarction risk correlation of ischemic cardiomyopathy based on bioinformatics.基于生物信息学的缺血性心肌病易感性基因及心肌梗死风险相关性分析
J Thorac Dis. 2022 Sep;14(9):3445-3453. doi: 10.21037/jtd-22-1060.
9
Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy.缺血性心肌病炎症相关基因潜在生物标志物的鉴定。
Front Cardiovasc Med. 2022 Aug 23;9:972274. doi: 10.3389/fcvm.2022.972274. eCollection 2022.
10
Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach.基于网络药理学方法揭示益肺健脾汤治疗新型冠状病毒肺炎的作用机制。
Comput Intell Neurosci. 2022 Jul 16;2022:1493137. doi: 10.1155/2022/1493137. eCollection 2022.
基质重塑相关蛋白 5(MXRA5)在良性前列腺增生中的鉴定和功能活性。
Aging (Albany NY). 2020 May 11;12(9):8605-8621. doi: 10.18632/aging.103175.
4
Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology.缺血性心肌病。病理生理见解、诊断管理以及血运重建和器械治疗的作用。先进技术时代的差距与困境。
Eur J Heart Fail. 2020 May;22(5):789-799. doi: 10.1002/ejhf.1747. Epub 2020 Feb 5.
5
Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.细胞外基质蛋白聚糖纤连蛋白适度缺失可减轻压力超负荷小鼠的心脏纤维化。
Cardiology. 2020;145(3):187-198. doi: 10.1159/000505318. Epub 2020 Jan 22.
6
The protective effects of grape seed procyanidin B2 against asporin mediates glycated low-density lipoprotein induced-cardiomyocyte apoptosis and fibrosis.葡萄籽原花青素B2对阿spor蛋白的保护作用介导了糖化低密度脂蛋白诱导的心肌细胞凋亡和纤维化。 (注:原文中“asporin”可能有误,推测可能是“aspirin”之类的词,但按给定原文准确翻译如上)
Cell Biol Int. 2020 Jan;44(1):268-277. doi: 10.1002/cbin.11229. Epub 2019 Sep 18.
7
The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload.细胞外基质蛋白聚糖 lumican 可提高小鼠在压力超负荷下的存活率,并对抗心脏扩张和衰竭。
Sci Rep. 2019 Jun 24;9(1):9206. doi: 10.1038/s41598-019-45651-9.
8
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.缺血性和非缺血性心力衰竭中的细胞外基质。
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
9
Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer.抑瘤素 M 促进胃癌细胞增殖的作用及其机制研究
Front Biosci (Landmark Ed). 2019 Jun 1;24(6):1178-1189. doi: 10.2741/4774.
10
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.缺血性心脏病引起的心力衰竭的医学治疗。
Circ Res. 2019 May 24;124(11):1520-1535. doi: 10.1161/CIRCRESAHA.118.313568.